CHASTITY HEATH: Open Payments
NPI 1003205857 · OXFORD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,275 in 98 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $2,996 · 2025 $2,275
Food & beverage: $2,275
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $334 |
| PFIZER INC. | 17 | $275 |
| Amgen Inc. | 9 | $206 |
| Philips North America LLC | 8 | $155 |
| Alnylam Pharmaceuticals Inc. | 3 | $135 |
| E.R. Squibb & Sons, L.L.C. | 3 | $125 |
| Abbott Laboratories | 1 | $123 |
| Merck Sharp & Dohme LLC | 5 | $116 |
| Novartis Pharmaceuticals Corporation | 5 | $104 |
| ABIOMED | 4 | $102 |
Products named: Kerendia, Repatha, VYNDAQEL, Ambulatory Monitoring & Diagnostics Undivided, AMVUTTRA, ELIQUIS, CAMZYOS, JOT DX.
Industry payments across MS — which companies pay providers there.
